AI Verdict
FHI has stronger fundamentals based on our AI analysis.
FHTX vs FHI Fundamental Comparison
| Metric | FHTX | FHI |
|---|---|---|
| Revenue | $30.9M | $1.8B |
| Net Income | $-74.3M | $403.3M |
| Net Margin | -240.3% | 22.4% |
| ROE | N/A | 33.7% |
| ROA | -37.5% | 18.1% |
| Current Ratio | 2.73x | 2.75x |
| Debt/Equity | N/A | 0.29x |
| EPS | $-1.18 | $5.13 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
FHTX vs FHI: Frequently Asked Questions
Is FHTX or FHI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), FHI has stronger fundamentals. FHTX is rated STRONG SELL (92% confidence) while FHI is rated STRONG BUY (88% confidence). This is not investment advice.
How does FHTX compare to FHI fundamentally?
Foghorn Therapeutics Inc. has ROE of N/A vs FEDERATED HERMES, INC.'s 33.7%. Net margins are -240.3% vs 22.4% respectively.
Which stock pays higher dividends, FHTX or FHI?
FHTX has a dividend yield of N/A or no dividend while FHI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in FHTX or FHI for long term?
For long-term investing, consider that FHTX has STRONG SELL rating with 92% confidence, while FHI has STRONG BUY rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about FHTX vs FHI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For FHTX vs FHI, the AI consensus favors FHI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.